ESR1 and obesity disorder: Our study demonstrates that enhanced DNA methylation at the Esr1 promoter by HFD plays an important role in mediating exaggerated adipose chemotaxis and inflammation, which may contribute to obesity-induced insulin resistance and type 2 diabetes.